Mualliflar

  • Ихтиярова Г.А., Курбанова З.Ш.

##semicolon##

синдром формирующихся поликистозных яичников, гормональный профиль, андрогены, инсулинорезистентность, HOMA-IR, антимюллеров гормон, витамин D, гомоцистеин.

##submission.citations##

Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057.

Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., … Lee, M. M. (2017). An International Consortium Update: Pathophysiology, diagnosis, and treatment of polycystic ovary syndrome in adolescence. Hormone Research in Paediatrics, 88(6), 371–395.

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., … Norman, R. J. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602–1618.

Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews, 37(5), 467–520.

Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012). Overweight, obesity and central obesity in women with polycystic ovary syndrome. Human Reproduction Update, 18(6), 618–637.

Barber, T. M., & Franks, S. (2021). Obesity and polycystic ovary syndrome. Clinical Endocrinology, 95(4), 531–541.

Wehr, E., Pieber, T. R., & Obermayer-Pietsch, B. (2011). Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study. Journal of Endocrinological Investigation, 34(10), 757–763.

Chakraborty, P., Goswami, S. K., Rajani, S., Sharma, S., Kabir, S. N., & Chak-ravarty, B. (2013). Recurrent pregnancy loss in polycystic ovary syndrome: Role of hyperhomocysteinemia and insulin resis-tance. PLoS ONE, 8(5), e64446.